{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:04:29Z","timestamp":1760547869162},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1980,1,1]],"date-time":"1980-01-01T00:00:00Z","timestamp":315532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1980]]},"DOI":"10.1007\/bf00561479","type":"journal-article","created":{"date-parts":[[2004,11,20]],"date-time":"2004-11-20T11:49:13Z","timestamp":1100951353000},"page":"55-63","source":"Crossref","is-referenced-by-count":30,"title":["Pharmacokinetics of diuretics and methylxanthines in the neonate"],"prefix":"10.1007","volume":"18","author":[{"given":"J. V.","family":"Aranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Turmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betty I.","family":"Sasyniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(76)80478-7","volume":"89","author":"JV Aranda","year":"1976","unstructured":"Aranda JV, Cohen S, Neims AG (1976) Drug utilization in a newborn intensive care unit. J Pediatr 89: 315?317","journal-title":"J Pediatr"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0095-5108(18)31165-5","volume":"6","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Turmen T (1979) Methylxanthines in apnea of prematurity. Clin Perinatol6: 87?108","journal-title":"Clin Perinatol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3181\/00379727-123-31391","volume":"123","author":"B Calesnick","year":"1966","unstructured":"Calesnick B, Christensen JA, Richter M (1966) Absorption and excretion of furosemide-S35 in human subjects. Proc Soc Exp Biol Med 123: 17?22","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00613429","volume":"9","author":"B Beermann","year":"1975","unstructured":"Beermann B, Dal\u00e9n E, Lindstr\u00f6m B, Rosen A (1975) On the fate of furosemide in man. Eur J Clin Pharmacol 9: 57?61","journal-title":"Eur J Clin Pharmacol"},{"key":"CR5","first-page":"404","volume":"149","author":"JB Hook","year":"1965","unstructured":"Hook JB, Williamson HE (1965) Influence of probenecid and alterations in acid-base balance of the saluretic activity of furosemide. J Pharmacol Exp Ther 149: 404?408","journal-title":"J Pharmacol Exp Ther"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cpt1974156588","volume":"15","author":"RE Cutler","year":"1974","unstructured":"Cutler RE, Forrey AW, Christopher TG, Kimpel EM (1974) Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clin Pharmacol Ther 15: 588?596","journal-title":"Clin Pharmacol Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0021-9673(01)94754-5","volume":"101","author":"B Lindstr\u00f6m","year":"1974","unstructured":"Lindstr\u00f6m B, Molander M (1974) Gas chromatographic determination of furosemide in plasma using an extractive alkylation technique and an electron capture detector. J Chromatogr 101: 219?221","journal-title":"J Chromatogr"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpt197722170","volume":"22","author":"B Beermann","year":"1977","unstructured":"Beermann B, Dal\u00e9n E, Lindstr\u00f6m B (1977) Elimination of furosemide in healthy subjects and in those with renal failure. Clin Pharmacol Ther 22: 70?78","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2125.1977.tb00682.x","volume":"4","author":"RA Branch","year":"1977","unstructured":"Branch RA, Roberts CJC, Homeida M, Levine D (1977) Determinants of response to furosemide in normal subjects. Br J Clin Pharmacol 4: 121?127","journal-title":"Br J Clin Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00561400","volume":"12","author":"F Andreasen","year":"1977","unstructured":"Andreasen F, Mikkelsen E (1977) Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Eur J Clin Pharmacol 12: 15?22","journal-title":"Eur J Clin Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-3476(78)81181-0","volume":"93","author":"JV Aranda","year":"1978","unstructured":"Aranda JV, Perez J, Sitar DS, Collinge J, Portuguez-Malavasi A, Duffy B, Dupont C (1978) Pharmacokinetic disposition and protein binding of furosemide in newborn infants. J Pediatr 93: 507?511","journal-title":"J Pediatr"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1203\/00006450-197804001-00268","volume":"12","author":"RG Peterson","year":"1978","unstructured":"Peterson RG, Rumack BH, Brooks JG (1978) Furosemide pharmacokinetics in the premature newborn. Pediatr Res 12: 407","journal-title":"Pediatr Res"},{"key":"CR13","unstructured":"Aranda JV, Perez J, Sitar DS (1980) Altered pharmacokinetic disposition of furosemide with multiple dosing. (Unpublished observation)"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3476(69)80284-2","volume":"75","author":"CM Edelmann","year":"1969","unstructured":"Edelmann CM, Spitzer A (1969) The maturing kidney. J Pediatr 75: 509?519","journal-title":"J Pediatr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3476(75)80136-3","volume":"86","author":"JMH Loggie","year":"1975","unstructured":"Loggie JMH, Kleinman LI, Van Maanen EF (1975) Renal function and diuretic therapy in infants and children, part I. J Pediatr 86: 485?496","journal-title":"J Pediatr"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cpt1974164659","volume":"16","author":"CM Huang","year":"1974","unstructured":"Huang CM, Atkinson AJ, Levin M, Levin NM, Quintanilla A (1974) Pharmacokinetics of furosemide in advanced renal failure. Clin Pharmacol Ther 16: 659?666","journal-title":"Clin Pharmacol Ther"},{"key":"CR17","unstructured":"Aranda JV, Sitar DS, Collinge J, Shaw D (1980) Metabolism of furosemide in the newborn infant. (Manuscript in preparation)"},{"key":"CR18","first-page":"710","volume":"14","author":"A H\u00e4ussler von","year":"1964","unstructured":"H\u00e4ussler von A, Hajd\u00fa P (1964) Untersuchungen mit dem Salidiureticum 4-Chlor-N-(furylmethyl)-5-sulfamyl-anthranils\u00e4ure. Arzneim Forsch 14: 710?713","journal-title":"Arzneim Forsch"},{"key":"CR19","first-page":"81","volume":"15","author":"A H\u00e4ussler von","year":"1965","unstructured":"H\u00e4ussler von A, Wicha H (1965) Untersuchungen mit dem Salidiureticum 4-Chlor-N-(furylmethyl)-5-sulfamyl-anthranils\u00e4ure. Arzneim Forsch 15: 81?83","journal-title":"Arzneim Forsch"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00606681","volume":"13","author":"F Andreasen","year":"1978","unstructured":"Andreasen F, Hansen HE, Mikkelsen E (1978) Pharmacokinetics of furosemide in anephric patients and in normal subjects. Eur J Clin Pharmacol 13: 41?48","journal-title":"Eur J Clin Pharmacol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3476(78)80098-5","volume":"92","author":"BS Ross","year":"1978","unstructured":"Ross BS, Pollak AP, Oh W (1978) The pharmacologic effects of furosemide therapy in the low birth weight infant. J Pediatr 92: 149?152","journal-title":"J Pediatr"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/cpt1978233266","volume":"23","author":"WCR Woo","year":"1978","unstructured":"Woo WCR, Dupont C, Collinge J, Aranda JV (1978) Effects of furosemide in the newborn. Clin Pharm Ther 23: 266?271","journal-title":"Clin Pharm Ther"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3476(77)80392-2","volume":"90","author":"S Shankaran","year":"1977","unstructured":"Shankaran S, Poland RL (1977) The displacement of bilirubin from albumin by furosemide. J Pediatr 90: 642?646","journal-title":"J Pediatr"},{"key":"CR24","first-page":"396","volume":"14","author":"K Duchin","year":"1974","unstructured":"Duchin K, Hutcheon D (1974) Renal pharmacology of bumetanide. A new sulfamoylmetanilic acid diuretic. J Clin Pharmacol 14: 396","journal-title":"J Clin Pharmacol"},{"key":"CR25","first-page":"66","volume":"22","author":"EH \u00d8stergaard","year":"1972","unstructured":"\u00d8stergaard EH, Magnussen MP, Nielsen CK, Eilertsen E, Frey H-H (1972) Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulphamylbenzoic acid (bumetanide), a new potent diuretic. Arzneim Forsch 22: 66?72","journal-title":"Arzneim Forsch"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-3476(77)80393-4","volume":"90","author":"RP Wennberg","year":"1977","unstructured":"Wennberg RP, Rasmussen LF, Ahlfors CE (1977) Displacement of bilirubin from human albumin by three diuretics. J Pediatr 90: 647?650","journal-title":"J Pediatr"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1203\/00006450-197404000-00153","volume":"8","author":"J Prandota","year":"1974","unstructured":"Prandota J, Pruitt AW (1974) Effect of albumin and drug concentration on the binding of furosemide. Pediatr Res 8: 365","journal-title":"Pediatr Res"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cpt1974152141","volume":"15","author":"DL Davies","year":"1974","unstructured":"Davies DL, Lant AF, Millard NR, Smith AJ, Ward JW, Wilson GM (1974) Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide. Clin Pharmacol Ther 15: 141?155","journal-title":"Clin Pharmacol Ther"},{"key":"CR29","first-page":"288","volume":"14","author":"T Turmen","year":"1980","unstructured":"Turmen T, Thom P, Louridas T, Aranda JV (1980) Protein binding and bilirubin displacement properties of bumetanide and furosemide. Pediatr Res 14: 288","journal-title":"Pediatr Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-3476(77)80718-X","volume":"90","author":"JV Aranda","year":"1977","unstructured":"Aranda JV, Gorman W, Bernsteinsson H, Gunn T (1977) Efficacy of caffeine in treatment of apnea in the low-birth-weight infant. J Pediatr 90: 467?472","journal-title":"J Pediatr"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-3476(79)80370-4","volume":"94","author":"TR Gunn","year":"1979","unstructured":"Gunn TR, Metrakos K, Riley P, Willis D, Aranda JV (1979) Sequelae of caffeine treatment in preterm infants with apnea. J Pediatr 94: 106?109","journal-title":"J Pediatr"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(78)80084-5","volume":"92","author":"MJ Davi","year":"1978","unstructured":"Davi MJ, Sankaran K, Simons KJ, Simons FER, Seshia MM, Rigatto H (1978) Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. J Pediatr 92: 91?95","journal-title":"J Pediatr"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197608192950803","volume":"295","author":"JV Aranda","year":"1976","unstructured":"Aranda JV, Sitar DS, Parsons WD, Loughnan PM, Neims AH (1976) Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 295: 413?416","journal-title":"N Engl J Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/cpt1977215633","volume":"21","author":"AL Neese","year":"1977","unstructured":"Neese AL, Soyka LF (1977) Development of a radioimmunoassay for theophylline: application to studies in premature infants. Clin Pharmacol Ther 21: 633?641","journal-title":"Clin Pharmacol Ther"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00609983","volume":"13","author":"R Latini","year":"1978","unstructured":"Latini R, Assael BM, Bonati M, Caccamo ML, Gerna M, Mandelli M, Marini A, Sereni F, Tognoni G (1978) Kinetics and efficacy of theophylline in the treatment of apnea in the premature newborn. Eur J Clin Pharmacol 13: 203?207","journal-title":"Eur J Clin Pharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3476(76)80818-9","volume":"89","author":"G Giacoia","year":"1976","unstructured":"Giacoia G, Jusko WJ, Menke J, Koup JR (1976) Theophylline pharmacokinetics in premature infants with apnea. J Pediatr 89: 829?832","journal-title":"J Pediatr"},{"key":"CR37","first-page":"677","volume":"32","author":"G Cottancin","year":"1977","unstructured":"Cottancin G, Baltassat P, Bory C, Challamel MJ, Frederich A (1977) Pharmacocinetique de la theophylline chez le nouveau n\u00e9 de petit poid de naissance. Pediatrie 32: 677?684","journal-title":"Pediatrie"},{"key":"CR38","first-page":"341","volume":"33","author":"JL Brazier","year":"1978","unstructured":"Brazier JL, Renaud H, Ribon B, Faucon G, Sassard G (1978) Evolution du taux plasmatique des xanthines dans le traitement de l'apnee du premature. Th\u00e9rapie 33: 341?355","journal-title":"Th\u00e9rapie"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3476(79)80248-6","volume":"94","author":"MJ Boutroy","year":"1979","unstructured":"Boutroy MJ, Vert P, Royer RJ, Monin P, Royer-Morrot MJ (1979) Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. J Pediatr 94: 996?998","journal-title":"J Pediatr"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000455516","volume":"1","author":"DM Hilligoss","year":"1980","unstructured":"Hilligoss DM, Jusko WJ, Koup JR, Giacoia G (1980) Factors affecting theophylline pharmacokinetics in premature infants with apnea. Dev Pharmacol Ther 1: 6?15","journal-title":"Dev Pharmacol Ther"},{"key":"CR41","first-page":"39","volume":"134","author":"FER Simons","year":"1980","unstructured":"Simons FER, Friesen FR, Simons KJ (1980) Theophylline toxicity in term infants. Am J Dis Child 134: 39?41","journal-title":"Am J Dis Child"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(79)80047-5","volume":"94","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn infant with apnea. J Pediatr 94: 663?668","journal-title":"J Pediatr"},{"key":"CR43","first-page":"1013","volume":"11","author":"R Gorodischer","year":"1977","unstructured":"Gorodischer R, Karplus M, Worszowski D, Bark H, Moses SW, Gordon C (1977) Caffeine pharmacokinetics in the neonate: Human and animal studies. Pediatr Res 11: 1013","journal-title":"Pediatr Res"},{"key":"CR44","first-page":"333","volume":"10","author":"W Parsons","year":"1976","unstructured":"Parsons W, Aranda JV, Neims AH (1976) Elimination of caffeine in the newborn. Pediatr Res 10: 333","journal-title":"Pediatr Res"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-197803040-00002","volume":"3","author":"RI Ogilvie","year":"1978","unstructured":"Ogilvie RI (1978) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3: 267?293","journal-title":"Clin Pharmacokinet"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/adc.54.12.946","volume":"54","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Collinge JM, Zinman R, Watters G (1979) Maturation of caffeine elimination in infancy. Arch Dis Child 54: 946?949","journal-title":"Arch Dis Child"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00561480","volume":"18","author":"H Lagercrantz","year":"1980","unstructured":"Lagercrantz H, Rane A, Tunell R (1980) Plasma concentration-effect relationship of theophylline in treatment of apnea in preterm infants. Eur J Clin Pharmacol 18: 65?68","journal-title":"Eur J Clin Pharmacol"},{"key":"CR48","unstructured":"Turmen T, Zinman R, Aranda JV (1978) Relationship of dose and plasma concentrations of caffeine and ventilation in neonatal apnea. Clin Res 26: 838A"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-82-6-784","volume":"82","author":"CW Zwillich","year":"1975","unstructured":"Zwillich CW, Sutton FD Jr, Neff TA, Cohn WM, Matthay RA, Weinberger MM (1975) Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med 82: 784?787","journal-title":"Ann Intern Med"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cpt1979254447","volume":"25","author":"A Aldridge","year":"1979","unstructured":"Aldridge A, Aranda JV, Neims AH (1979) Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447?453","journal-title":"Clin Pharmacol Ther"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0024-3205(75)90343-4","volume":"16","author":"MG Horning","year":"1975","unstructured":"Horning MG, Butler CM, Nowlin J, Hill RM (1975) Drug metabolism in the human neonate. Life Sci 16: 651?672","journal-title":"Life Sci"},{"key":"CR52","first-page":"185","volume":"13","author":"S Sved","year":"1976","unstructured":"Sved S, Hossie RD, McGilveray IJ (1976) The human metabolism of caffeine to theophylline. Res Commun Chem Pathol Pharmacol 13: 185?192","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/bms.1200040309","volume":"4","author":"KK Midha","year":"1977","unstructured":"Midha KK, Sved S, Hossie RD, McGilveray IJ (1977) High performance liquid chromatographic and mass spectrometric identification of dimethylxanthine metabolites of caffeine in human plasma. Biomed Mass Spectrom 4: 172?177","journal-title":"Biomed Mass Spectrom"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9258(18)70714-X","volume":"228","author":"HH Cornish","year":"1957","unstructured":"Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theophylline and caffeine in man. J Biol Chem 228: 315?323","journal-title":"J Biol Chem"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cpt1976193375","volume":"19","author":"JW Jenne","year":"1976","unstructured":"Jenne JW, Nagasawa HT, Thompson RD (1976) Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 19: 375?381","journal-title":"Clin Pharmacol Ther"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1203\/00006450-198002000-00092","volume":"14","author":"M Bonati","year":"1980","unstructured":"Bonati M, Latini R, Marre G, Assael BM, Parini R (1980) Theophylline metabolism in the premature neonate. Pediatr Res 14: 176","journal-title":"Pediatr Res"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3476(79)80246-2","volume":"94","author":"C Bory","year":"1979","unstructured":"Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1979) Metabolism of theophylline to caffeine in the premature newborn infant. J Pediatr 94: 988?993","journal-title":"J Pediatr"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0022-3476(79)80247-4","volume":"94","author":"HS Bada","year":"1979","unstructured":"Bada HS, Khanna NN, Somani SM, Tin AA (1979) Interconversion of theophylline and caffeine in newborn infants. J Pediatr 94: 993?995","journal-title":"J Pediatr"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1126\/science.515734","volume":"206","author":"JV Aranda","year":"1979","unstructured":"Aranda JV, Louridas AT, Vitullo BB, Thom P, Aldridge A, Haber R (1979) Metabolism of theophylline to caffeine in human fetal liver. Science 206: 1319?1321","journal-title":"Science"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00561479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00561479\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00561479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T06:15:31Z","timestamp":1624947331000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00561479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1980]]}},"alternative-id":["BF00561479"],"URL":"https:\/\/doi.org\/10.1007\/bf00561479","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980]]}}}